User login


Report: U.S. should use CFIUS, export controls to address China's growing biotech sector

February 14, 2019 at 4:29 PM
A new report ordered by the U.S.-China Economic and Security Review Commission recommends that the U.S. use the Committee on Foreign Investment in the U.S. and export controls, along with increased international cooperation, to mitigate the effects of China’s burgeoning biotechnology sector, which could present long-term risks and disadvantage U.S. companies. The report, released by the Commission, was prepared by research firms Gryphon Scientific and Rhodium Group at the USCC's request. The USCC was chartered by Congress in 2000 to...

Not a subscriber? Sign up for 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Trump administration.